Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Medtronic Get FDA Clearance of TrailBlazer Angled Peripheral Support Catheter
Medtronic plc announced that the U.S. Food and Drug Administration (FDA) has cleared the TrailBlazer(TM) angled support catheter for use in the peripheral vascular system. Support catheters such as the Trailblazer are often used in endovascular procedures treating complex peripheral artery disease (PAD). FDA clearance was received on September 23, 2016.
- Read more about AstraZeneca presents new data on Faslodex at ESMO 2016 congress
AstraZeneca, along with its global biologics research and development arm, MedImmune, will showcase the growing potential of its broad portfolio of cancer medicines through 46 scientific presentations, at the European Society for Medical Oncology (ESMO) 2016 Congress in Copenhagen, Denmark, from 7-11 October 2016.
- Read more about Zymeworks and Daiichi Sankyo Announce Immuno-Oncology Cross-Licensing Agreement and Bi-Specific Antibody Collaboration
Zymeworks Inc., and Daiichi Sankyo Company, Limited announced that they have entered into a cross-licensing and collaboration agreement to develop proprietary cancer immuno-oncology products
- Read more about Aegerion Pharma get Japanese approval for Juxtapid
Aegerion Pharmaceuticals, Inc. announced that Japan's Ministry of Health, Labor & Welfare (MHLW) has approved Juxtapid for patients with homozygous familial hypercholesterolemia (HoFH).

[adsense:336x280:8701650588]
- Read more about Daiichi Sankyo Initiates Phase 3 study of CS-3150 for Treatment of Essential Hypertension
Daiichi Sankyo Company, Limited announced that it has initiated a Phase 3 pivotal study of CS-3150 (esaxerenone (r-INN)), its non-steroidal, selective novel mineralocorticoid receptor (MR) antagonist, for patients in Japan with essential hypertension.
- Read more about Daiichi Sankyo to present phase 1 data evaluating DS-8201a at ESMO 2016 congress
Daiichi Sankyo Company, Limited announced that safety and preliminary efficacy phase 1 data evaluating DS-8201a, a novel HER2-targeting antibody drug conjugate, will be presented during a late-breaking poster discussion session during the European Society for Medical Oncology (ESMO) 2016 Congress from October 7 -11 in Copenhagen, Denmark.
- Read more about Medtronic Receives FDA Approval for World's First Hybrid Closed Loop System
Medtronic plc announced it has received U.S. Food and Drug Administration (FDA) approval of its MiniMed® 670G system - the first Hybrid Closed Loop insulin delivery system approved anywhere in the world. Featuring the company's most advanced algorithm - SmartGuard(TM) HCL - the system is the latest innovation in Medtronic's phased approach toward developing a fully automated, closed loop system.
- Read more about Medtronic's StealthStation® Cranial Software Receives FDA Clearance
Medtronic plc announced U.S. Food and Drug Administration (FDA) clearance of StealthStation® Cranial Software as an aid for deep brain stimulation (DBS) lead placement. The software is fully integrated with Medtronic's latest O-arm® Imaging System, providing clinicians with a complete procedural solution for the planning and placement of DBS leads. The announcement was made at the Congress of Neurological Surgeons (CNS) in San Diego.
- Read more about Some Herbal and Dietary Supplements Can Be Toxic to the Live
A new review based on a research symposium sponsored by the American Association for the Study of Liver Disease and the National Institutes of Health highlights the potentially damaging effects of herbal and dietary supplements (HDSs) on the liver.
- Read more about Antibiotics developed in 1960s show promise for TB therapy
First generation cephalosporins antibiotics introduced as a treatment against bacterial infections in 1963 now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.